{"id":"W4392382353","doi":"10.1016/j.lungcan.2024.107529","title":"Outcomes of patients with advanced epithelial growth factor receptor mutant lung cancer treated with first-line osimertinib who would not have met the eligibility criteria for the FLAURA clinical trial","year":2024,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Osimertinib; Internal medicine; Lung cancer; Population; T790M; Clinical trial; Oncology; Cohort; Cancer; Surgery; Epidermal growth factor receptor; Gefitinib; Erlotinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008534355,0.0002859178,0.001068775,0.0001741774,0.0004431295,0.00100341,0.0003282624,0.0008331069,0.001972706],"category_scores_gemma":[0.001708213,0.0001182685,0.002377774,0.0003809235,0.0003518712,0.0007346128,0.0004061431,0.001328978,0.000257142],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001204551,"about_ca_system_score_gemma":0.0007356002,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00156702,"about_ca_topic_score_gemma":0.002861659,"domain_scores_codex":[0.9995357,0.0001437871,0.00004148599,0.00007918326,0.00005891346,0.0001410605],"domain_scores_gemma":[0.9992756,0.0001449902,0.000231697,0.00004019204,0.00006242438,0.0002451273],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2423188,0.003311209,0.6208577,0.0008124242,0.005577255,0.001014422,0.0003150196,0.005695767,0.00454382,0.002349441,0.02019499,0.09300914],"study_design_scores_gemma":[0.03831748,0.04708075,0.8861211,0.0002701451,0.005079706,0.001217114,0.0005174939,0.005452471,0.001223832,0.00428427,0.01031268,0.0001229108],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9900682,0.002608928,0.0001936308,0.001400793,0.0002174566,0.00008928889,0.001993372,0.000009981478,0.00341843],"genre_scores_gemma":[0.9954982,0.000470309,0.000061518,0.000642516,0.0001568277,0.0000830416,0.002372637,0.000003545536,0.0007112892],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001972706,"threshold_uncertainty_score":0.00873965,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0368810711503858,"score_gpt":0.4325912659763442,"score_spread":0.3957101948259584,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}